Ligand efficiency indices for effective drug discovery
- 1 April 2007
- journal article
- Published by Informa Healthcare in Expert Opinion on Drug Discovery
- Vol. 2 (4), 469-488
- https://doi.org/10.1517/17460441.2.4.469
Abstract
Successful drug discovery requires the optimization of a large number of variables ranging from strictly physicochemical parameters such as molecular weight to more complex parameters related to toxicity and bioavailability. Presently, structure-based methodologies influence many aspects of the drug discovery process from lead discovery to the final preclinical characterization. However, critical biological issues along the path to the market have diminished the impact and power of this methodology. The physicochemical properties of the novel chemical entities designed and guided by structural methods have become the subject of intense scrutiny from lead discovery to drug candidate. The idea of ligand efficiency (binding energy/non-hydrogen atoms) has recently emerged as a useful guide to optimize fragment and lead selection in the discovery process. More generalized concepts of ligand efficiency, related to efficiency per dalton and per unit of polar surface area, have also been introduced and will be di...Keywords
This publication has 61 references indexed in Scilit:
- Chemical screening methods to identify ligands that promote protein stability, protein crystallization, and structure determinationProceedings of the National Academy of Sciences, 2006
- Synergistic Use of Protein Crystallography and Solution‐phase NMR Spectroscopy in Structure‐based Drug Design: Strategies and TacticsPublished by Wiley ,2006
- Fragment‐based Lead Discovery and Optimization Using X‐Ray Crystallography, Computational Chemistry, and High‐throughput Organic SynthesisPublished by Wiley ,2006
- Dependence of Molecular Properties on Proteomic Family for Marketed Oral DrugsJournal of Medicinal Chemistry, 2006
- Computational chemistry-driven decision making in lead generationDrug Discovery Today, 2006
- A ‘Rule of Three’ for fragment-based lead discovery?Drug Discovery Today, 2003
- Identification of “Latent Hits” in Compound Screening CollectionsJournal of Medicinal Chemistry, 2003
- Improving the Odds in Discriminating “Drug-like” from “Non Drug-like” CompoundsJournal of Chemical Information and Computer Sciences, 2000
- The Genome Sequence of Drosophila melanogasterScience, 2000
- The Protein Data BankNucleic Acids Research, 2000